BACKGROUND AND PURPOSE: In patients with multiple sclerosis (MS), a few preliminary functional MR (fMR) imaging studies of the visual cortex reveal information about magnitude differences between healthy individuals and patients with MS at only a single luminance level. We therefore investigated whether varying luminance contrast levels can help uncover subtle changes in fMR imaging characteristics of the visual cortex in healthy volunteers and patients with MS. METHODS: Blood oxygenation level-dependent fMR imaging signal changes in the primary visual cortex were examined as a function of luminance contrast at 1.5 T in 10 healthy volunteers and nine patients with MS. Ten axial sections through the calcarine fissure were obtained with an echo-planar T2*-weighted imaging sequence (4000/54/1 [TR/TE/excitation]; field of view, 220 mm; voxel size, 1.72 x 1.72 x 5 mm). The imaging series consisted of an alternating 20-second rest epoch (black screen) with a 20-second activation epoch (flickering checkerboard) repeated six times. Each imaging series used a graded increase of eight luminance contrast levels. A paired t test between rest and activation images was used to analyze significant (P <.001) contiguous voxels in the region of interest (primary visual cortex). RESULTS: A progressive increase in fMR imaging activation across all luminance contrast levels in healthy controls and patients with MS was shown. The patients with MS had a significantly lower magnitude in the number of fMR imaging activated voxels at all luminance contrast levels (P <.001). A statistically significant increase in fMR imaging activation (activation threshold) was seen at the second luminance contrast level in controls and at the seventh level in patients with MS. CONCLUSION: Quantifiable changes in blood oxygenation level-dependent signal and a progressive increase in activated voxels within the primary visual cortex with increasing luminance contrast were demonstrated at 1.5 T in controls. The patients with MS showed a significant decrease in the number of activated voxels and an increase in activation threshold compared with healthy controls.
BACKGROUND AND PURPOSE: In patients with multiple sclerosis (MS), a few preliminary functional MR (fMR) imaging studies of the visual cortex reveal information about magnitude differences between healthy individuals and patients with MS at only a single luminance level. We therefore investigated whether varying luminance contrast levels can help uncover subtle changes in fMR imaging characteristics of the visual cortex in healthy volunteers and patients with MS. METHODS: Blood oxygenation level-dependent fMR imaging signal changes in the primary visual cortex were examined as a function of luminance contrast at 1.5 T in 10 healthy volunteers and nine patients with MS. Ten axial sections through the calcarine fissure were obtained with an echo-planar T2*-weighted imaging sequence (4000/54/1 [TR/TE/excitation]; field of view, 220 mm; voxel size, 1.72 x 1.72 x 5 mm). The imaging series consisted of an alternating 20-second rest epoch (black screen) with a 20-second activation epoch (flickering checkerboard) repeated six times. Each imaging series used a graded increase of eight luminance contrast levels. A paired t test between rest and activation images was used to analyze significant (P <.001) contiguous voxels in the region of interest (primary visual cortex). RESULTS: A progressive increase in fMR imaging activation across all luminance contrast levels in healthy controls and patients with MS was shown. The patients with MS had a significantly lower magnitude in the number of fMR imaging activated voxels at all luminance contrast levels (P <.001). A statistically significant increase in fMR imaging activation (activation threshold) was seen at the second luminance contrast level in controls and at the seventh level in patients with MS. CONCLUSION: Quantifiable changes in blood oxygenation level-dependent signal and a progressive increase in activated voxels within the primary visual cortex with increasing luminance contrast were demonstrated at 1.5 T in controls. The patients with MS showed a significant decrease in the number of activated voxels and an increase in activation threshold compared with healthy controls.
Authors: K Imamura; H Richter; H Fischer; G Lennerstrand; O Franzén; A Rydberg; J Andersson; H Schneider; H Onoe; Y Watanabe; B Långström Journal: Neurosci Lett Date: 1997-04-11 Impact factor: 3.046
Authors: C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte Journal: Ann Neurol Date: 1983-03 Impact factor: 10.422
Authors: C Mainero; N De Stefano; G Iannucci; M P Sormani; L Guidi; A Federico; M L Bartolozzi; G Comi; M Filippi Journal: Neurology Date: 2001-05-22 Impact factor: 9.910
Authors: J Foong; L Rozewicz; G Quaghebeur; C A Davie; L D Kartsounis; A J Thompson; D H Miller; M A Ron Journal: Brain Date: 1997-01 Impact factor: 13.501
Authors: R W Beck; P A Cleary; J D Trobe; D I Kaufman; M J Kupersmith; D W Paty; C H Brown Journal: N Engl J Med Date: 1993-12-09 Impact factor: 91.245
Authors: R B Tootell; J B Reppas; K K Kwong; R Malach; R T Born; T J Brady; B R Rosen; J W Belliveau Journal: J Neurosci Date: 1995-04 Impact factor: 6.167
Authors: M Filippi; A Campi; S Mammi; V Martinelli; T Locatelli; G Scotti; S Amadio; N Canal; G Comi Journal: J Neurol Neurosurg Psychiatry Date: 1995-01 Impact factor: 10.154
Authors: Madhan Kolappan; Andrew P D Henderson; Thomas M Jenkins; Claudia A M Wheeler-Kingshott; Gordon T Plant; Alan J Thompson; David H Miller Journal: J Neurol Date: 2009-03-18 Impact factor: 4.849
Authors: Dingcai Cao; Andrew J Zele; Joel Pokorny; David Y Lee; Leonard V Messner; Christopher Diehl; Susan Ksiazek Journal: Invest Ophthalmol Vis Sci Date: 2011-11-17 Impact factor: 4.799
Authors: Rachael Stickland; Marek Allen; Lorenzo Magazzini; Krish D Singh; Richard G Wise; Valentina Tomassini Journal: Neuroscience Date: 2018-03-23 Impact factor: 3.590